Neuropeptide FF and neuropeptide VF inhibit GABAergic neurotransmission in parvocellular neurons of the rat hypothalamic paraventricular nucleus

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 292, Issue 5, 2007, Pages

  Jhamandas, Jack H ^a   Simonin, Frédéric ^b   Bourguignon, Jean Jacques ^c   Harris, Kim H ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^c UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

Electrophysiology; Morphine modulatory peptide; RFamide

Indexed keywords

BICUCULLINE; KYNURENIC ACID; NEUROPEPTIDE; NEUROPEPTIDE FF; NEUROPEPTIDE VF; RECEPTOR BLOCKING AGENT; RF 9; TETRODOTOXIN; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CARDIOVASCULAR EFFECT; CONTROLLED STUDY; DEPOLARIZATION; ELECTROSTIMULATION; GABAERGIC TRANSMISSION; IN VITRO STUDY; MALE; NERVE CONDUCTION; NEUROTRANSMISSION; NONHUMAN; PATCH CLAMP; POSTSYNAPTIC INHIBITION; PRESYNAPTIC INHIBITION; PRIORITY JOURNAL; RAT; THALAMUS MIDLINE NUCLEUS; VOLTAGE CLAMP;

ANIMALS; BICUCULLINE; CELLS, CULTURED; ELECTROPHYSIOLOGY; GABA ANTAGONISTS; GAMMA-AMINOBUTYRIC ACID; MALE; NARCOTIC ANTAGONISTS; NEURONS; NEUROPEPTIDES; OLIGOPEPTIDES; PARAVENTRICULAR HYPOTHALAMIC NUCLEUS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 34248136386     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00407.2006     Document Type: Article

References (40)

1. Aarnisalo AA, Panula P. Neuropeptide FF-containing efferent projections from the medial hypothalamus of rat: a Phaseolus vulgaris leucoagglutinin study. Neuroscience 65: 175-192, 1995.
2. Arima H, Murase T, Kondo K, Iwasaki Y, Oiso Y. Centrally administered neuropeptide FF inhibits arginine vasopressin release in conscious rats. Endocrinology 137:1523-1529, 1996.
3. Baimoukhametova DV, Hewitt SA, Sank CA, Bains JS. Dopamine modulates use-dependent plasticity of inhibitory synapses. J Neurosci 24: 5162-5171, 2004.
4. Bains JS, Ferguson AV. Nitric oxide regulates NMDA driven GABAergic inputs to type I neurons of the rat paraventricular nucleus. J Physiol 499: 733-746, 1997.
5. Boersma CJ, Sonnemans MA, Van Leeuwen FW. Immunocytochemical localization of neuropeptide FF (FMRF amide-like peptide) in the hypothalamo-neurohypophyseal system of Wistar and Brattleboro rats by light and electron microscopy. J Comp Neurol 336: 555-570, 1993.
6. Bonini JA, Jones KA, Adham N, Forray C, Artymyshyn R, Durkin MM, Smith KE, Tamm JA, Boteju LW, Lakhlani PP, Raddatz R, Yao WJ, Ogozalek KL, Boyle N, Kouranova EV, Quan Y, Vaysse PJ, Wetzel JM, Branchek TA, Gerald C, Borowsky B. Identification and characterization of two G protein-coupled receptors for neuropeptides FF. J Biol Chem 275: 39324-39331, 2000.
7. Decavel C, Dubourg P, Leon-Henri B, Geffard M, Calas A. Simultaneous immunogold labeling of GABAergic terminals and vasopressin- containing neurons in the rat paraventricular nucleus. Cell Tissue Res 255: 77-80, 1989.
8. Engstrom M, Brandt A, Wurster S, Savola JM, Panula P. Prolactin releasing peptide has high affinity and efficacy at neuropeptide FF2 receptors. J Pharmacol Exp Ther 305: 825-832, 2003.
9. A receptors. Nature 6: 215-229, 2005.
10. Goncharuk V, Zeng Z, Wang R, MacTavish D, Jhamandas JH. Distribution of the neuropeptide FF1 receptor (hFF1) in the human hypothalamus and surrounding basal forebrain structures: Immunohistochemical study. J Comp Neurol 474: 487-503, 2004.
11. 125]EYF as selective radioligands. Neuroscience 115: 349-361, 2002.
12. 2) in the rat, mouse, octodon, rabbit, guinea pig and marmoset monkey brain: a comparative autoradiographic study. Synapse 51: 249-269, 2004.
13. Hinuma S, Shitani Y, Fukusumi S, Iijima N, Matsumoto Y, Hosoya M, Fujii R, Watanabe T, Kikuchi K, Terao Y, Yano T, Yamamoto T, Kawamata Y, Habata Y, Asada M, Kitada C, Kurokawa T, Onda H, Nishimura O, Tanaka M, Ibata Y, Fujino M. New neuropeptides containing carboxy-terminal RFamide and their receptor in mammals. Nat Cell Biol 2: 703-708, 2000.
14. Hoffman NW, Tasker JG, Dudek FE. Immunohistochemical differentiation of electrophysiologically defined neuronal populations in the region of the rat hypothalamic paraventricular nucleus. J Comp Neurol 307: 405-416, 1991.
15. Jhamandas JH, Jhamandas A, Harris KH. New central projections of neuropeptide FF (NPFF): collateral branching pathways in the brainstem and hypothalamus in the rat. J Chem Neuroanat 21: 171-179, 2001.
16. Jhamandas JH, MacTavish D. Central administration of neuropeptide FF (NPFF) causes increased neuronal activation and upregulation of NPFF gene expression in the rat brainstem. J Comp Neurol 447: 300-307, 2002.
17. Jhamandas JH, MacTavish D. Central administration of neuropeptide FF causes activation of oxytocin paraventricular neurons that project to the brain stem. J Neuroendocrinol 15: 24-32, 2003.
18. Jhamandas JH, MacTavish D, Harris KH. Neuropeptide FF (NPFF) control of magnocellular neurosecretory cells of the rat hypothalamic paraventricular nucleus (PVN). Peptides 27: 973-979, 2006.
19. Kasai M, Osaka T, Inenaga K, Kannan H, Yamashita H. γ-Aminobutyric acid antagonist blocks baroreceptor-activated inhibition of neurosecretory cells in the hypothalamic paraventricular nucleus of rats. Neurosci Lett 81: 319-324, 1987.
20. Kenney MJ, Weiss ML, Haywood JR. The paraventricular nucleus: an important component of the central neurocircuitry regulating sympathetic nerve outflow. Acta Physiol Scand 177: 7-15, 2003.
21. Latchford KJ, Ferguson AV. Angiotensin II activates a nitric-oxidedriven inhibitory feedback in the rat paraventricular nucleus. J Neurophysiol 89: 1238-1244, 2003.
22. Li DP, Chen SR, Pan HL. Angiotensin II stimulates spinally projecting paraventricular neurons through presynaptic disinhibition. J Neurosci 23: 5041-5049, 2003.
23. Li DP, Pan HL. Plasticity of GABAergic control of hypothalamic presympathetic neurons in hypertension. Am J Physiol Heart Circ Physiol 290: H1110-H1119, 2006.
24. Li YF, Jackson KL, Stern JE, Rabeler B, Patel KP. Interaction between glutamate and GABA systems in the integration of sympathetic outflow by the paraventricular nucleus of the hypothalamus. Am J Physiol Heart Circ Physiol 291: H2847-H2856, 2006.
25. Liu Q, Guan XM, Martin WJ, McDonald TP, Clemens MK, Jiang Q, Zeng Z, Jacobson M, Williams DL Jr, Yu H, Bomford D, Figuroa D, Mallee J, Wang R, Evans J, Gould R, Austin CP. Identification and characterization of novel mammalian neuropeptide FF-like peptides that attenuate morphine-induced antinociception. J Biol Chem 276: 36961-36969, 2001.
26. Luther JA, Daftary SS, Boudaba C, Gould GC, Halmos KC, Tasker JG. Neurosecretory and non-neurosecretory parvocellular neurones of the hypothalamic paraventricular nucleus express distinct electrophysiological properties. J Neuroendocrinol 14: 929-932, 2002.
27. Martin DS, Haywood JR. Hemodynamic responses to paraventricular nucleus disinhibition with bicuculline in conscious rats. Am J Physiol Heart Circ Physiol 265: H1727-H1733, 1993.
28. 2 receptors of the NPY ligands GR231118n and BIBP3226. Br J Pharmacol 133: 1-4, 2001.
29. Panula P, Aarnisalo AA, Wasowich K. Neuropeptide FF, a mammalian neuropeptide with multiple functions. Prog Neurobiol 48: 461-487, 1996.
30. Panula P, Kalso K, Nieminen M, Kontinen VK, Brandt A, Pertovaara A. Neuropeptide FF and modulation of pain. Brain Res 848: 191-196, 1999.
31. A synaptic responses of rat medial parvocellular effector neurons in the hypothalamic paraventricular nucleus. Endocrinology 143: 535-543, 2002.
32. Roland BL, Sawchenko PE. Local origins of some GABAergic projections to the paraventricular and supraoptic nuclei of the hypothalamus in the rat. J Comp Neurol 332: 123-143, 1993.
33. Roumy M, Zajac JM. Neuropeptide FF, pain and analgesia. Eur J Pharmacol 345: 1-11, 1998.
34. Semayanov A, Walker MC, Kullmann DM. GABA uptake regulates cortical excitability via cell type-specific tonic inhibition. Nat Neurosci 6: 484-490, 2003.
35. Simonin F, Schmitt M, Laulin JP, Laboureyras E, Jhamandas JH, MacTavish D, Matifas A, Mollereau C, Laurent P, Parmentier M, Kieffer BL, Bourguignon JJ, Simonnet G. RF9, a potent and selective neuropeptide FF receptor antagonist, prevents opioid-induced tolerance associated with hyperalgesia. Proc Natl Acad Sci USA 103: 466-471, 2006.
36. Swanson LW, Sawchenko PE. Hypothalamic integration: organization of the paraventricular and supraoptic nuclei. Annu Rev Neurosci 6: 269-324, 1983.
37. Tasker JG, Dudek FE. Electrophysiological properties of neurones in the region of the paraventricular nucleus in slices of rat hypothalamus. J Physiol 434: 271-293, 1991.
38. Vilim FS, Aarnisalo AA, Nieminen ML, Lintunen M, Karlstedt K, Kontinen VK, Kalso E, States B, Panula P, Ziff E. Gene for pain modulatory neuropeptide NPFF: induction in spinal cord by noxious stimuli. Mol Pharmacol 55: 804-811, 1999.
39. Zajac JM. Neuropeptide FF: new molecular insights. Trends Pharmacol Sci 22: 63, 2001.
40. Zhang K, Li YF, Patel KP. Reduced endogenous GABA-mediated inhibition in the PVN on renal nerve discharge in rats with heart failure. Am J Physiol Regul Integr Comp Physiol 282: R10006-R10015, 2002.